Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of 5% minoxidil foam in adult women with androgenetic alopecia
CTR20250387Phase 3Completed
- Sponsor
- 3SBio
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by 3SBio. Started Mar 2025; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on CTR20250387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250387.